American Medical Systems v. Celsion
This article was originally published in The Gray Sheet
Executive Summary
Patent settlement calls for Celsion to pay American Medical Systems a licensing fee and ongoing royalty payments on sales of its Prolieve Thermodilatation system for benign prostatic hyperplasia, distributed by Boston Scientific. Announced Feb. 8, the settlement relates to patents covering AMS' TherMatrx microwave system for non-obstructive BPH. The deal resolves litigation initiated by AMS in Delaware federal court last September. Celsion denies any wrongdoing...